Impedimed Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 104

Employees

  • Stock Symbol
  • IPD

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.05
  • (As of Wednesday Closing)

Impedimed General Information

Description

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Stock Exchange
ASX
Corporate Office
  • Unit 1
  • 50 Parker Court
  • Pinkenba, Queensland 4008
  • Australia
+61 (07) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impedimed Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.05 - $0.16 $106M 2.02B 1.99M

Impedimed Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021
EV 96,964 211,137 46,706 103,248
Revenue 7,562 7,605 6,227
EBITDA (14,268) (12,375) (14,117)
Net Income (13,796) (14,402) (15,437)
Total Assets 45,499 40,380 25,699
Total Debt 958 117 356
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impedimed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impedimed‘s full profile, request access.

Request a free trial

Impedimed Patents

Impedimed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230346239-A1 Impedance measurement device Pending 28-Apr-2022 000000000
AU-2019348188-A1 Evaluating impedance measurements Pending 27-Sep-2018 0000000000
US-20220007956-A1 Evaluating impedance measurements Pending 27-Sep-2018 0000000000
EP-3856024-A1 Evaluating impedance measurements Pending 27-Sep-2018 0000000000
EP-3856024-A4 Evaluating impedance measurements Pending 27-Sep-2018 A61B5/0537 0
To view Impedimed’s complete patent history, request access »

Impedimed Executive Team (14)

Name Title Board Seat Contact Info
Parmjot Bains Interim Chief Executive Officer & Managing Director
McGregor Grant Interim Chief Financial Officer & Chairman
Shashi Tripathi Chief Operating Officer
David Anderson Executive Director & Executive Consultant
Steven Chen MD Chief Medical Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Impedimed Board Members (4)

Name Representing Role Since
Amit Patel Self Non-Executive Director 000 0000
McGregor Grant Impedimed Interim Chief Financial Officer & Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Impedimed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impedimed Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Intersection Medical 26-Oct-2015 0000000000 Surgical Devices 0000000 0
XiTRON Technologies 01-Oct-2007 Merger/Acquisition Electronic Equipment and Instruments 0000000 0
To view Impedimed’s complete acquisitions history, request access »

Impedimed ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Impedimed’s complete esg history, request access »

Impedimed Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
XiTRON Technologies 01-Oct-2007 000000000000000000 Completed
  • 000000000
To view Impedimed’s complete exits history, request access »

Impedimed FAQs

  • When was Impedimed founded?

    Impedimed was founded in 1999.

  • Who is the CEO of Impedimed?

    Parmjot Bains is the CEO of Impedimed.

  • Where is Impedimed headquartered?

    Impedimed is headquartered in Pinkenba, Australia.

  • What is the size of Impedimed?

    Impedimed has 104 total employees.

  • What industry is Impedimed in?

    Impedimed’s primary industry is Monitoring Equipment.

  • Is Impedimed a private or public company?

    Impedimed is a Public company.

  • What is Impedimed’s stock symbol?

    The ticker symbol for Impedimed is IPD.

  • What is the current stock price of Impedimed?

    As of 29-May-2024 the stock price of Impedimed is $0.05.

  • What is the current market cap of Impedimed?

    The current market capitalization of Impedimed is $106M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »